Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
29.09
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Dec 5, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,118
Open
29.09
Bid (Size)
29.11 (1)
Ask (Size)
29.14 (1)
Prev. Close
29.09
Today's Range
29.09 - 29.09
52wk Range
28.30 - 54.93
Shares Outstanding
5,606,688,356
Dividend Yield
5.64%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Diamonds in the Rough: 3 Undervalued Stocks with Huge Upside
December 05, 2023
These three, undervalued stocks that have reliable and massive earnings growth potential may yield a pleasant surprise.
Via
InvestorPlace
Arvinas and Pfizer Announce Interim Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) and Plans to Expand Vepdegestrant Development Program
December 05, 2023
From
Arvinas Inc.
Via
GlobeNewswire
Performance
YTD
-43.25%
-43.25%
1 Month
-6.70%
-6.70%
3 Month
-17.78%
-17.78%
6 Month
-26.82%
-26.82%
1 Year
-42.66%
-42.66%
More News
Read More
While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer
December 05, 2023
Via
Benzinga
3 Stocks at the Forefront of Personalized Medicine Trend
December 05, 2023
Via
InvestorPlace
This Is What Whales Are Betting On Pfizer
December 04, 2023
Via
Benzinga
Is Pfizer Stock a Buy Now?
December 03, 2023
Via
The Motley Fool
Why Pfizer Stock Is Sinking Today
December 01, 2023
Via
The Motley Fool
7 Compelling Stocks to Buy That are Sitting at 52-Week Lows
December 05, 2023
Via
InvestorPlace
Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market
December 04, 2023
Via
Benzinga
Roche Stock Rises On $3.1 Billion Deal For Obesity Drugmaker
December 04, 2023
Via
Investor's Business Daily
Ozempic vs. Mounjaro:: Battle of the bulge
December 04, 2023
Via
MarketBeat
Exposures
Product Safety
Pfizer Tumbles After Abandoning Weight-Loss Pill
December 02, 2023
Via
Talk Markets
Pfizer Inc. (NYSE: PFE) is One of Friday Morning’s Most Active Stocks
December 01, 2023
Via
Investor Brand Network
Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes
December 02, 2023
Via
The Motley Fool
An Important History Lesson for Gene-Editing Investors
December 02, 2023
Via
The Motley Fool
5 Top Stocks to Buy Before 2024
December 02, 2023
Via
The Motley Fool
Stocks, Gold, Bonds Rally Further, Dollars Tumbles As Traders Anticipate Fed Cuts: What's Driving Markets Friday?
December 01, 2023
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why Is Hub Cyber Security (HUBC) Stock Up 30% Today?
December 01, 2023
Via
InvestorPlace
Why Is Altimmune (ALT) Stock Up 43% Today?
December 01, 2023
Via
InvestorPlace
Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts
December 01, 2023
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Texas Attorney General Alleges Pfizer Misled Public on COVID-19 Vaccine Efficacy
December 01, 2023
Via
Benzinga
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Pfizer Halts Development Of Twice-Daily Weight-Loss Drug; PFE Stock Slides
December 01, 2023
Via
Investor's Business Daily
Dow Jones Hits 2023 High, Nasdaq Slips; Tesla Cybertruck, Salesforce In Focus: Weekly Review
December 01, 2023
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Pfizer’s Stock Is Down 44% YTD As Woes Continue
December 01, 2023
Via
Talk Markets
Tale Of Two Investigational Obesity Drugs: Altimmune Stock Jumps, While Pfizer Trades Lower
December 01, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.